[1]
“THE EFFECT OF SGLT2 INHIBITOR THERAPY ON THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE”, scientific, vol. 86, no. 2, pp. 148–150, Jan. 2026, Accessed: Feb. 28, 2026. [Online]. Available: https://journalss.org/index.php/obr/article/view/16527